Innodata (NASDAQ:INOD) reported record second-quarter results for 2026, with revenue, adjusted gross profit, adjusted EBITDA and cash reaching new highs as the company continued to expand its work with AI model developers and large technology customers.
Revenue for the quarter was $92.1 million, up
iRhythm Technologies (NASDAQ:IRTC) reported second-quarter revenue growth of 20.1% and raised its full-year outlook, while announcing an agreement to acquire VitalConnect to broaden its cardiac monitoring portfolio and enter additional patient-monitoring markets.
Revenue for the quarter ended at $2
indie Semiconductor (NASDAQ:INDI) reported second-quarter 2026 revenue of $64 million, up 24% from a year earlier and $2 million above the midpoint of its outlook, as growth in automotive advanced-driver-assistance systems and demand for its radar, vision and photonics products supported results.
C
Inogen (NASDAQ:INGN) reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business.
The company lowered its full-y
INmune Bio (NASDAQ:INMB) outlined plans to file for conditional approval of its Ebstrocel cell therapy in the United Kingdom by the end of the third quarter or early in the fourth quarter of 2026, while reporting a narrower second-quarter net loss and cash runway into the second quarter of 2027.
Ch
ICU Medical (NASDAQ:ICUI) reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
Adj
Hyperfine (NASDAQ:HYPR) reported second-quarter revenue of $3.9 million, up approximately 45% from a year earlier, as the portable MRI company cited growth across hospital, neurology office and international markets.
The company sold 12 systems during the quarter, compared with eight in the prior-y
ICF International (NASDAQ:ICFI) reported second-quarter 2026 revenue that was essentially unchanged from a year earlier as growth in commercial, international and other non-federal markets offset a year-over-year decline in federal revenue. Management said the company remains on track to return to y
Health Catalyst (NASDAQ:HCAT) reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
Chief Executive Officer Ben
Halozyme Therapeutics (NASDAQ:HALO) reported record second-quarter revenue and raised its full-year outlook, citing growth in royalty income from its ENHANZE drug-delivery platform, contributions from newer product launches and revenue from newly signed collaboration agreements.
Total revenue rose
Fox Factory (NASDAQ:FOXF) reported second-quarter 2026 revenue at the high end of its guidance range and adjusted EBITDA above expectations, while raising its full-year sales outlook and maintaining its cost-savings target amid elevated commodity, freight and fuel expenses.
Revenue for the second q
JFrog (NASDAQ:FROG) reported second-quarter 2026 results above the high end of its guidance, with revenue growth led by cloud consumption, security-product adoption and larger enterprise commitments.
Total revenue rose 29% year over year to $163.8 million. Cloud revenue increased 53% to $87.5 milli
Gen Digital (NASDAQ:GEN) reported first-quarter fiscal 2027 results that exceeded its guidance, with revenue, bookings and earnings rising at double-digit rates as growth in trust-based solutions complemented continued momentum in its core cyber-safety business.
Chief Executive Officer Vincent Pile
Gevo (NASDAQ:GEVO) reported second-quarter revenue growth and raised its full-year adjusted EBITDA outlook, citing stronger performance in its low-carbon fuels and carbon businesses, higher expected tax-credit monetization, and newly approved access to Canada’s clean-fuel market.
Revenue for the se
Five9 (NASDAQ:FIVN) reported second-quarter 2026 revenue of $312 million, up 10% from a year earlier and above the high end of its guidance range, as accelerating artificial intelligence revenue helped drive subscription growth.
Subscription revenue rose 14% year over year, marking a third consecut
Full House Resorts (NASDAQ:FLL) reported second-quarter revenue growth of 5.6% and a 19.5% increase in adjusted EBITDA, led by continued gains at its American Place temporary casino in Waukegan, Illinois, and improving results at the Chamonix Casino Hotel in Colorado.
President, CFO and Treasurer L
